EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma

Dandan Zhu, Huolun Feng, Zhixiong Zhang, Jiaqi Li, Yong Li iD, Tieying Hou iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Dandan Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Center for Clinical Laboratory, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Adenocarcinoma, Tumor Microenvironment, GTPase-Activating Proteins. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Nanshan District Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent research indicates a positive correlation between DEP structural domain‐containing 1B (DEPDC1B) and the cell cycle in various tumors. However, the role of DEPDC1B in the infiltration of the tumor immune microenvironment (TIME) remains unexplored.

Methods

We analyzed the differential expression and prognostic significance of DEPDC1B in colon adenocarcinoma (COAD) using the R package “limma” and the Gene Expression Profiling Interactive Analysis (GEPIA) website. Gene set enrichment analysis (GSEA) was employed to investigate the functions and interactions of DEPDC1B expression in COAD. Cell Counting Kit‐8 (CCK‐8) assays and colony formation assays were utilized to assess the proliferative function of DEPDC1B. Correlations between DEPDC1B expression and tumor‐infiltrating immune cells, immune checkpoints, tumor mutational burden (TMB), and microsatellite instability (MSI) status were examined using Spearman correlation analysis and CIBERSORT.

Results

DEPDC1B was highly expressed in COAD. Elevated DEPDC1B expression was associated with lower epithelial‐to‐mesenchymal transition (EMT) and TNM stages, leading to a favorable prognosis. DEPDC1B mRNA was prominently expressed in COAD cell lines. CCK‐8 and colony formation assays demonstrated that DEPDC1B inhibited the proliferation of COAD cells. Analysis using the CIBERSORT database and Spearman correlation revealed that DEPDC1B correlated with four types of tumor‐infiltrating immune cells. Furthermore, high DEPDC1B expression was linked to the expression of PD‐L1, CTLA4, SIGLEC15, PD‐L2, TMB, and MSI‐H. High DEPDC1B expression also indicated responsiveness to anti‐PD‐L1 immunotherapy.

Conclusions

DEPDC1B inhibits the proliferation of COAD cells and positively regulates the cell cycle, showing a positive correlation with CCNB1 and PBK expression. DEPDC1B expression in COAD is associated with tumor‐infiltrating immune cells, immune checkpoints, TMB, and MSI‐H in the tumor immune microenvironment. This suggests that DEPDC1B may serve as a novel prognostic marker and a potential target for immunotherapy in COAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsAdenocarcinomaTumor MicroenvironmentGTPase-Activating ProteinsGene Expression Regulation, NeoplasticHumansPrognosisCell Line, TumorCell ProliferationLymphocytes, Tumor-InfiltratingEpithelial-Mesenchymal TransitionGenes, Tumor SuppressorBiomarkers, TumorMicrosatellite InstabilityMaleB7-H1 AntigenCyclin B1Female

Stichwörter der Autor:innen

biomarkercell cyclecolon adenocarcinomaimmunotherapytumor‐infiltrating immune cells

Substanzen

GTPase-Activating ProteinsBiomarkers, TumorB7-H1 AntigenCD274 protein, humanCyclin B1

Autor:innen und Institutionen

  • Guangdong Center for Clinical Laboratory, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
  • School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
  • Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
  • Medical Experimental Center, Shenzhen Nanshan People's Hospital, Shenzhen, Guangdong, China.
  • Medical School, Shenzhen University, Shenzhen, Guangdong, China.

ORCID-Profile: Yong Li, Tieying Hou

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Nanshan District Science and Technology Plan Project
  • Nanshan District Health Major Special Project

Zitieren

APA

Zhu, D., Feng, H., Zhang, Z., Li, J., Li, Y., & Hou, T. (2024). DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70043

Vancouver

Zhu D, Feng H, Zhang Z, Li J, Li Y, Hou T. DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.70043

BibTeX
@article{Zhu2024,
  author = {Zhu, Dandan and Feng, Huolun and Zhang, Zhixiong and Li, Jiaqi and Li, Yong and Hou, Tieying},
  title = {DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70043}
}
Kostenlos starten →